Catalyst Wire Dossier Catalyst Wire Dossier

LIVTENCITY

MARIBAVIR · Takeda Pharmaceuticals America, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for LIVTENCITY, covering 2021-11-23 to 2025-11-21. Get the full timeline:

Most recent: FDA Approved: LIVTENCITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing